Ann: Althea Reaches 2329 Patients After Record Month, page-14

Talked with a couple people over the weekend, apparently recent share price weakness stems from the Canadian/US companies.

ASX cannabis companies that have big overseas cannabis companies as cornerstones on their registers are now taken to be a negative, as there is a perception that these overseas companies will need to sell down holdings in the ASX companies to free up cash.

I personally think its ludicrous, and to your point Aphria already has arguably the strongest balance sheet out of their peers.

At least now the sell down over the past few weeks makes more sense. CAN suffered heavily as well, AC8 a bit but no so much. Are there any other ASX cannabis co with overseas cornerstones?

So basically just another opportunity to buy in from panicked investors akin to December when the AGH SP tanked 70% on Aprhia short attack.